Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | +3.12% | +4.76% | 0.00% |
03-08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
03-05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 177M | |
+1.77% | 42.86B | |
+45.32% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- CGEN Stock
- News Compugen Ltd.
- Compugen : Commences Dosing in Phase 1 Trial of Combo Therapy for Advanced Malignancies